Flowcytometry: Absolute CD19 count

The Flowcytometry: Absolute CD19 count test is a specialized flow cytometry assay used to measure the number of CD19-positive B lymphocytes in the blood. CD19 is a surface marker found on B cells, which are responsible for producing antibodies that protect the body against infections. This test helps evaluate immune system status and monitor patients undergoing treatments like bone marrow transplantation, immunotherapy, or chemotherapy. It is also useful in diagnosing and tracking diseases such as leukemia, lymphoma, and primary immunodeficiency disorders. By accurately quantifying B-cell levels, the test provides essential information for clinicians to assess immune reconstitution and guide treatment response. The test requires a blood sample and is performed using advanced flow cytometry technique that quickly identifies and measures different types of blood cells to help diagnose and monitor immune and blood-related conditions.

Please note: This is an outsourced test. The sample is collected by TATA 1MG and processed at a NABL accredited partnered lab.